Indegene’s Kay Uttech was awarded the Engagement Achievement Award by the Healthcare Businesswomen’s Association (HBA) for her contribution for promoting gender parity in the industry in 2021.
The award recognizes an individual who has demonstrated consistent leadership that positively impacted member engagement, fostered collaboration, and promoted overall excellence in furthering the HBA mission.
HBA, whose mission is to help achieve gender parity in leadership positions in healthcare, facilitate business and connections and help organizations realize the full potential of their female talent, recognized Uttech for her exemplary role in supporting this goal and bringing in lot more engaged members to the organization.
Uttech began her role on the HBA Southeast Regional Council as a Membership and Engagement Regional Director. In that role, she streamlined the volunteer and award process so that the regional council members could traverse the process seamlessly.
Uttech, who is currently is Vice President, Strategic Initiatives, at Indegene, said, “I want to thank the amazing team in the SE region and the HBA home office who have been instrumental in ensuring that members are connected to HBA and the volunteer opportunities available that can help them advance their career.”
Indegene is a technology-led healthcare solutions provider, combining industry expertise with fit-for-purpose technology in an agile and scalable operating model.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.